Our results indicate that the higher prostatic AKR1C3 transcript levels in patients with T2D could be responsible for an increased androgen receptor level or activation, which was previously detected in the prostate glands of patients with T2D [37]. The gene discussed is AR; the disease is type 2 diabetes mellitus.